T. Canarelli, Rapport 2010 -Données ré centes relatives aux traitements de substitution aux opiacé s. Available: http://www.ofdt.fr/ofdtdev, 2013.

A. Rahimi-movaghar, M. Amin-esmaeili, M. Hefazi, and R. Yousefi-nooraie, Pharmacological therapies for maintenance treatments of opium dependence, Cochrane Database of Systematic Reviews, vol.31, issue.3, 2013.
DOI : 10.1254/jjp.31.433

A. Winstock, T. Lea, and J. Sheridan, Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia, International Journal of Drug Policy, vol.19, issue.6, pp.450-458, 2008.
DOI : 10.1016/j.drugpo.2007.03.002

D. Grau, N. Vidal, V. Faucherre, Y. Lé-glise, and V. Pinzani, Complications infectieuses induites par le m??susage de la bupr??norphine haut dosage (Subutex??)??: analyse r??trospective de 42??observations, La Revue de M??decine Interne, vol.31, issue.3, pp.188-193, 2010.
DOI : 10.1016/j.revmed.2009.10.433

R. Bollinger, A. Preuss, P. Mcclain, W. Hill, and . Jr, Study of particulate matter in carbenicillin disodium using scanning electron microscopy and microbeam x-ray spectrography, Am J Hosp Pharm, vol.35, pp.312-317, 1978.

N. Davis, S. Turco, and E. Sivelly, A study of particulate matter in I.V. infusion fluids, Am J Hosp Pharm, vol.27, pp.822-826, 1970.

P. Deluca, R. Rapp, B. Bivins, H. Mckean, and W. Griffen, Filtration and infusion phlebitis: a double-blind prospective clinical study, Am J Hosp Pharm, vol.32, pp.1001-1007, 1975.

W. Evans, L. Barker, and J. Simone, Double-blind evaluation of 5-mum final filtration to reduce postinfusion phlebitis, Am J Hosp Pharm, vol.33, pp.1160-1163, 1976.

H. Schroeder and P. Deluca, Particulate matter assessment of a clinical investigation on filtration and infusion phlebitis, Am J Hosp Pharm, vol.33, pp.543-546, 1976.

L. Wainstein, C. Bernier, M. Gé-rardin, R. Bouquié, and O. Espitia, Livedo-like dermatitis and necrotic lesions after high-dose buprenorphine injections: a national French survey, British Journal of Dermatology, vol.20, issue.5, 2014.
DOI : 10.1016/j.anplas.2008.12.004

D. Brewster, M. Humphrey, and M. Mcleavy, The systemic bioavailability of buprenorphine by various routes of administration, Journal of Pharmacy and Pharmacology, vol.26, issue.1, pp.500-506, 1981.
DOI : 10.1002/cpt1979262167

H. Hahn, Complications of Injecting Dissolved Methylphenidate Tablets, Archives of Internal Medicine, vol.123, issue.6, pp.656-659, 1969.
DOI : 10.1001/archinte.1969.00300160046008

R. Jenkinson, N. Clark, C. Fry, and M. Dobbin, Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?, Addiction, vol.282, issue.2, pp.197-205, 2005.
DOI : 10.1111/j.1476-5381.1977.tb07532.x

E. Hornez, J. Laroche, T. Monchal, S. Bourgouin, and P. Riviere, N??crose du gland apr??s injection volontaire de bupr??norphine dans un contexte de toxicomanie aux opio??des, Annales de Chirurgie Plastique Esth??tique, vol.55, issue.2, pp.159-161, 2010.
DOI : 10.1016/j.anplas.2008.12.004

M. Glaizal, J. Lucciardi, L. Tichadou, M. Spadari, and M. Hayek-lanthois, Syndrome isché mique distal sévè re aprè s injection intra-arté rielle volontaire de bupré norphine, Thé rapie, vol.66, pp.545-547, 2011.
DOI : 10.2515/therapie/2011069

F. Dressler and W. Roberts, Modes of death and types of cardiac diseases in opiate addicts: Analysis of 168 necropsy cases, The American Journal of Cardiology, vol.64, issue.14, pp.909-92010, 1989.
DOI : 10.1016/0002-9149(89)90841-2

J. Abraham and C. Brambilla, Particle size for differentiation between inhalation and injection pulmonary talcosis, Environmental Research, vol.21, issue.1, pp.94-96, 1980.
DOI : 10.1016/0013-9351(80)90011-0

J. Scott, Laboratory study of the effectiveness of filters used by heroin injectors, Journal of Substance Use, vol.155, issue.3, pp.293-301, 2005.
DOI : 10.1093/aje/155.7.645

P. Nicolau, Dermite livé do?¨dedo?¨de et gangré neuse de la fesse consé cutive aux injections intramusculaires de la syphilis, pp.20-321, 1925.

I. Modzelewska and A. Dawidowicz-szczepanowska, Nicolau syndrome following administration of procaine penicillin], Wiad Lek Wars Pol, vol.33, pp.231-233, 1960.

S. Nayci and M. Gurel, Nicolau syndrome following intramuscular diclofenac injection, Indian Dermatology Online Journal, vol.4, issue.2, pp.152-153, 2013.
DOI : 10.4103/2229-5178.110642

J. Zaragoza, M. Delaplace, and M. Benamara, Un effet ind??sirable rare de la m??soth??rapie??: la dermite de Nicolau, Annales de Dermatologie et de V??n??r??ologie, vol.140, issue.11, pp.713-717
DOI : 10.1016/j.annder.2013.07.009

B. Bellot, C. Bonnet, K. Retornaz, M. Panuel, and J. Garnier, Nicolau syndrome after intramuscular injection]. Arch Pé diatrie Organe Off Sociéte Fr Pé diatrie 21, 2014.

D. Guarneri and G. Polimeni, Nicolau Syndrome Following Etanercept Administration, American Journal of Clinical Dermatology, vol.156, pp.51-52, 2010.
DOI : 10.2165/1153426-S0-000000000-00000

S. Kim, T. Kim, and K. Lee, Nicolau Syndrome after Intramuscular Injection: 3 Cases, Archives of Plastic Surgery, vol.39, issue.3, 2012.
DOI : 10.5999/aps.2012.39.3.249

URL : http://www.e-aps.org/upload/pdf/aps-39-249.pdf

A. Cherasse, M. Kahn, R. Mistrih, H. Maillard, and J. Strauss, Nicolau???s syndrome after local glucocorticoid injection, Joint Bone Spine, vol.70, issue.5, pp.390-392, 2003.
DOI : 10.1016/S1297-319X(03)00137-4

D. Perli, C. Martone, and A. Rapose, Naltrexone-induced Nicolau syndrome masquerading as cutaneous abscess, Case Reports, vol.2012, issue.dec14 1, pp.10-1136, 2012.
DOI : 10.1136/bcr-2012-007785

URL : http://europepmc.org/articles/pmc4544998?pdf=render

C. Gaudez, S. Regnier, S. Aractingi, and O. Heinzlef, [Livedo-like dermatitis (Nicolau's syndrome) after injection of Copolymer-1 (Glatiramer acetate)], Rev Neurol, vol.159, pp.571-573, 2003.

J. Gayken, A. Westanmo, A. Knutsen, D. Ahrenholz, and W. Mohr, Livedoid Dermatitis and Severe Necrosis (Nicolau???s Syndrome) After Intramuscular Hydroxyzine Injection, Journal of Burn Care & Research, vol.25, issue.4, pp.541-544, 2006.
DOI : 10.1148/92.4.700

A. Kienast, D. Mentze, and P. Hoeger, Nicolau???s syndrome induced by intramuscular vaccinations in children: report of seven patients and review of the literature, Clinical and Experimental Dermatology, vol.101, issue.5, pp.555-558, 2008.
DOI : 10.1111/j.1600-0773.1983.tb01105.x

M. Corazza, O. Capozzi, and A. Virgili, Five cases of livedo-like dermatitis (Nicolau's syndrome) due to bismuth salts and various other non-steroidal anti-inflammatory drugs, Journal of the European Academy of Dermatology and Venereology, vol.39, issue.6, pp.585-588, 2001.
DOI : 10.1111/j.1399-6576.1995.tb04243.x

P. Ruffieux, D. Salomon, and J. Saurat, Livedo-Like Dermatitis (Nicolau???s Syndrome): A Review of Three Cases, Dermatology, vol.193, issue.4, pp.368-371, 1996.
DOI : 10.1159/000246298

G. Marangi, P. Gigliofiorito, V. Toto, M. Langella, and T. Pallara, Three cases of embolia cutis medicamentosa (Nicolau???s syndrome), The Journal of Dermatology, vol.163, issue.5, pp.488-492, 2010.
DOI : 10.1111/j.1346-8138.2010.00864.x

F. Brecheteau, P. Grison, P. Abraham, S. Lebdai, and S. Kemgang, Successful Medical Treatment of Glans Ischemia after Voluntary Buprenorphine Injection, The Journal of Sexual Medicine, vol.10, issue.11, pp.2866-2870, 2013.
DOI : 10.1111/jsm.12282

A. Potier, C. Leclech, A. Croue, D. Chappard, and J. Verret, Liv??do n??crotique apr??s injections de bupr??norphine (Subutex??) : r??le de l???amidon de ma??s contenu dans l???excipient, Necrotic livedo after injection of buprenorphine, pp.148-150, 2007.
DOI : 10.1016/S0151-9638(07)91607-5

P. Schneider, T. Duong, N. Ortonne, M. Bagot, and J. Bouaziz, Livedoid and Necrotic Skin Lesions Due to Intra-arterial Buprenorphine Injections Evidenced by Maltese Cross???Shaped Histologic Bodies, Archives of Dermatology, vol.146, issue.2, pp.208-209, 2010.
DOI : 10.1001/archdermatol.2009.372

J. Pierre-alexandre, L. François, S. Abdellah, T. Karim, and D. Christian, An Unusual Case of Livedoid and Necrotic Lesions in a Drug Addict, The American Journal of Dermatopathology, vol.29, issue.1, pp.72-74, 2007.
DOI : 10.1097/01.dad.0000211508.67736.d4

S. Standring and H. Gray, Gray's anatomy: the anatomical basis of clinical practice Edinburgh: Churchill Livingstone Available: http://www.mdconsult.com.ezp-prod1.hul.harvard, pp.127-14350014, 2008.

, Accessed, 2013.

A. Guyton and J. Hall, Human Physiology and Mechanisms of Disease. Sixth Edition, 1997.

P. Roux, M. Carrieri, L. Keijzer, and N. Dasgupta, Reducing harm from injecting pharmaceutical tablet or capsule material by injecting drug users, Drug and Alcohol Review, vol.5, issue.4, pp.287-290, 2011.
DOI : 10.1186/1477-7517-5-14

. Acadé-mie-nationale-de-pharmacie, Sé ance thé matique: Matiè res premiè res pharmaceutiques, Mondialisation et Santé Publique, 2011.